Jin L, Williamson A, Banerjee S, Philipp I, Rape M. Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex. Cell. 2008;133:653–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Newton K, Matsumoto ML, Wertz IE, Kirkpatrick DS, Lill JR, Tan J, et al. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell. 2008;134:668–78.

Article  CAS  PubMed  Google Scholar 

Walczak H, Iwai K, Dikic I. Generation and physiological roles of linear ubiquitin chains. BMC Biol. 2012;10:23.

Article  PubMed  PubMed Central  Google Scholar 

Wickliffe KE, Williamson A, Meyer HJ, Kelly A, Rape M. K11-linked ubiquitin chains as novel regulators of cell division. Trends Cell Biol. 2011;21:656–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kumar S, Yoshida Y, Noda M. Cloning of a cDNA which encodes a novel ubiquitin-like protein. Biochem. Biochem. Bioph. Res. Co. 1993;195:393–9.

Article  CAS  Google Scholar 

Soucy TA, Smith PG, Milhollen MA, Berger AJ, Langston SP. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature. 2009;458:732–6.

Article  CAS  PubMed  Google Scholar 

Yoshimura C, Muraoka H, Ochiiwa H, Tsuji S, Hashimoto A, Kazuno H, et al. TAS4464, A Highly Potent and Selective Inhibitor of NEDD8-Activating Enzyme, Suppresses Neddylation and Shows Antitumor Activity in Diverse Cancer Models. Mol. Cancer Thera. 2019;18:1205–16.

Article  CAS  Google Scholar 

Yamamoto N, Shimizu T, Yonemori K, Kitano S, Takahashi S. A first-in-human, phase 1 study of the NEDD8 activating enzyme E1 inhibitor TAS4464 in patients with advanced solid tumors. Investig New Drugs. 2021;39:1036–46.

Article  CAS  Google Scholar 

Lu P, Liu X, Yuan X, He M, Wang Y, Zhang Q, et al. Discovery of a novel NEDD8 Activating Enzyme Inhibitor with Piperidin-4-amine Scaffold by Structure-Based Virtual Screening. Acs Chem Biol. 2016;11:1901–06.

Article  CAS  PubMed  Google Scholar 

Liu X, Zhang L, Tan JG, Xu HH. Design and synthesis of N-alkyl-N′-substituted 2,4-dioxo-3,4-dihydropyrimidin-1-diacylhydrazine derivatives as ecdysone receptor agonist. Bioorg. Med. Chem. 2013;21:4687–97.

Article  CAS  PubMed  Google Scholar 

Moosa BA, Ali SA. Regioselective transformation of 6/5-fused bicyclic isoxazolidines to second-generation cyclic aldonitrones. Arkivoc. 2010;10:132–48.

Article  Google Scholar 

Jain N, Aeluri R, Alla M, et al. Synthesis and antiproliferative activity of imidazo[1,2-a]pyrimidine Mannich bases. Eur. J Med. Chem. 2015;100:18–23.

Article  PubMed  Google Scholar 

Zanin L, Jimenez D, Birolli W, Venncio T, Valdes T, Leito A, et al. Synthesis of 1,2,3-triazole Compounds by Click Chemistry in Aqueous Medium and Evaluation of Bactericidal and Antitumoral Properties. Curr Bioactive Compounds. 2022;18:10.

Article  Google Scholar 

Widler L, Green J, Missbach M, Ua M, Altmann E. 7-Alkyl- and 7-Cycloalkyl-5-aryl-pyrrolo[2,3- d]pyrimidines—potent inhibitors of the tyrosine kinase c-Src. Bioorg. Med. Chem. Lett. 2001;11:849–52.

Article  CAS  PubMed  Google Scholar 

Garcia J, Mata EG, Tice CM, Hormann RE, Michelotti EL. Evaluation of Solution and Solid-Phase Approaches to the Synthesis of Libraries of α,α-Disubstituted-α-acylaminoketones. J Comb. Chem. 2005;7:843–63.

Article  CAS  PubMed  Google Scholar 

Wang J, Li F, Pei W, Yang M, Wu Y, Ma D, et al. Selective cleavage of the N-propargyl group from sulfonamides and amides under ruthenium catalysis. Tetrahedron Lett. 2018;59:1902–5.

Article  CAS  Google Scholar 

Kettler K, Sakowski J, Wiesner J, Ortmann R, Jomaa H, Schlitzer M. Novel lead structures for antimalarial farnesyltransferase inhibitors. Pharmazie. 2005;60:323–27.

CAS  PubMed  Google Scholar 

Xu J, Berastegui-Cabrera J, Ye N, Carretero-Ledesma M, Zhou J. Discovery of Novel Substituted N-(4-Amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide Analogues as Potent Human Adenovirus Inhibitors. J. Med. Chem. 2020;63:12830–52.

Article  CAS  PubMed  Google Scholar 

Leipold F, Hussain S, Ghislieri D, Turner NJ. Asymmetric Reduction of Cyclic Imines Catalyzed by a Whole-Cell Biocatalyst Containing an (S)-Imine Reductase. Chemcatchem. 2013;5:3505–8.

Article  CAS  Google Scholar 

Hoque ME, Hassan MMM, Chattopadhyay B. Remarkably Efficient Iridium Catalysts for Directed C(sp 2)–H and C(sp 3)–H Borylation of Diverse Classes of Substrates. J. Am. Chem. Soc. 2021;143:5022–37.

Article  CAS  PubMed  Google Scholar 

Xu J, Chen J, Gao F, Xie S, Xu X, Jin Z, et al. Sequential Functionalization of meta-C-H and ipso-C-O Bonds of Phenols. J. Am. Chem. Soc. 2019;141:1903–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kumar R, Yar MS, Rai AK, Chaturvedi S. Synthesis and biological evaluation of some novel 1,3,4-oxadiazoles derived from bi phenyl 4-carboxylic acid. Der Pharm Lett. 2013;5:366–70.

CAS  Google Scholar 

Xian J, Wang S, Jiang Y, Li L, Cai L, Chen P, et al. Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma. 癌症生物学与医学: 英文版. 2022;004:019.

Google Scholar 

Li JA, Song C, Rong Y, Kuang T, Wang D, Xu X, et al. Chk1 inhibitor SCH 900776 enhances the antitumor activity of MLN4924 on pancreatic cancer. Cell Cycle. 2018;17:191–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Q, Hou D, Luo Z, Chen P, Lv B, Wu L, et al. The novel protective role of P27 in MLN4924-treated gastric cancer cells. Cell Death Dis. 2015;6:e1867.

Article  PubMed  PubMed Central  Google Scholar 

Li L, Kang J, Zhang W, Cai L, Jia L. Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer. EBioMedicine. 2019;45:81–91.

Article  PubMed  PubMed Central  Google Scholar